US-Canada Pilot Could Help FDA's OTC Monograph Update Fly
This article was originally published in The Tan Sheet
Executive Summary
HHS' latest semi-annual regulatory agenda lists a US-Canada Regulatory Cooperation Council pilot program as the source of a proposed rule to add the common cold indication for monograph OTC antihistamine ingredients that FDA plans to introduce in March 2016.
You may also be interested in...
With Deeming Rule Pending, FDA Reminds E-Cigarette Firms About Drug Claims
In a proposed rule, FDA describes to a new audience its long-established policy on drugs and devices marketed for off-label indications. The agency says “some ambiguity surrounds the circumstances” that determine whether a product is regulated as tobacco or as a drug, device or combination product
In Brief: FTC, FDA Enforcement; Insider Trading On NBTY Sale; Comment Period On Label Changes
FTC says Pure Green Coffee perks false claims; NBTY shareholder settles insider trading case; scientific citations trigger warning letter; supplement labels must detail plant source; scientific citations trigger warning; and more news In Brief.
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.